Sapropterin

DB00360ApprovedInvestigationalSmall moleculePhenylalanine Hydroxylase Activator

Sapropterin is a cofactor used as an adjunct to phenylalanine restriction in the treatment of phenylketonuria (PKU). Sapropterin (tetrahydrobiopterin or BH4) is a cofactor in the synthesis of nitric oxide.

Chemical structure of Sapropterin
Mechanism
Curator reviewed
Primary indication
For the treatment of tetrahydrobiopterin (BH4) deficiency.Curator reviewed · 1 structured indication
Formula / weight
C9H15N5O3 · 241.2471 g/mol (avg)
First approval
Canada, 2019 · United States, 2007 · European Union, 2020
Also known as
6R-BH4 · R-THBP · Tetrahydrobiopterin
Code names
17528-72-2 · 27070-47-9 · Sun 0588
Brand names
  • Javygtor
  • Kuvan
  • Sapropterin Dipharma
  • Zelvysia

Resolves to

Structure
InChIKeyFNKQXYHWGSIFBK-RPDRRWSUSA-NSMILES[H][C@@]1(CNC2=C(N1)C(=O)NC(N)=N2)[C@@H](O)[C@H](C)O
Transporters

What you can answer from here — as of September 21, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
174Drug interactionsStructured to mechanism, not free text
Sign in
57Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
65Marketed productsAcross 6 countries and 18 labellers
Sign in
1ATC codeIncluding every combination product, plus 18 drug categories
Sign in
27+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Sapropterin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account